Management strategies of neonatal jaundice during the coronavirus disease 2019 outbreak

Xiao-Lu Ma, Zheng Chen, Jia-Jun Zhu, Xiao-Xia Shen, Ming-Yuan Wu, Li-Ping Shi, Li-Zhong Du, Jun-Fen Fu, Qiang Shu, Xiao-Lu Ma, Zheng Chen, Jia-Jun Zhu, Xiao-Xia Shen, Ming-Yuan Wu, Li-Ping Shi, Li-Zhong Du, Jun-Fen Fu, Qiang Shu

Abstract

The outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV) has become a most challenging health emergency. Owing to rigorous quarantine and control measures taken in China, routine neonatal health surveillance and follow-up have become challenging. Without follow-up surveillance, some rapid and progressive newborn diseases, such as bilirubin encephalopathy, may be ignored. The characteristics of onset age of kernicterus suggest that monitoring of bilirubin level at home provides a useful way to alert hospital visits and to prevent the development of extremely hyperbilirubinemia. Therefore, we developed an online follow-up program for convenient monitoring of bilirubin level of newborns that is based on our practical experiences. The aim is to make our management strategies of neonatal jaundice tailored to the infection prevention and control during the COVID-19 epidemic.

Keywords: Follow-up; Hyperbilirubinemia; Internet hospital; New coronavirus pneumonia; Newborn.

Conflict of interest statement

The authors have no financial relationships relevance to the article to disclose.

References

    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. Coronavirus investigating, and research team A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 doi: 10.1056/NEJMoa2001017.
    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with novel coronavirus in Wuhan, China. Lancet. 2020 doi: 10.1016/S0140-6736(20)30183-5.
    1. Shen KL, Yang YH, Wang TY, Zhao DC, Jiang Y, Jin RM, et al. Diagnosis, treatment, and prevention of novel coronavirus infection in children: experts' consensus statement. World J Pediatr. 2020 doi: 10.1007/s12519-020-00343-7.
    1. Chen HJ, Guo JJ, Wang C, Luo F, Yu XC, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020 doi: 10.1016/s0140-6736(20)30360-3.
    1. Zhu HP, Wang L, Fang CZ, Peng SC, Zhang LH, Chang GP, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2019 doi: 10.21037/tp.2020.02.06.
    1. Du LZ, Ma XL. International perspectives: hyperbilirubinemia and kernicterus in neonates in China. NeoReviews. 2012;13:e141–e144. doi: 10.1542/neo.13-3-e141.
    1. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316. doi: 10.1542/peds.114.1.297.
    1. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103:6–14. doi: 10.1542/peds.103.1.6.
    1. Taylor JA, Stout JW, de Greef L, Goel M, Patel S, Chung EK, et al. Use of a smartphone app to assess neonatal jaundice. Pediatrics. 2017;140:e20170312. doi: 10.1542/peds.2017-0312.
    1. Rong ZH, Luo F, Ma LY, Chen L, Wu L, Liu W, et al. Evaluation of an automatic image-based screening technique for neonatal hyperbilirubinemia. Zhonghua Er Ke Za Zhi. 2016;54:597–600.
    1. Wang L, Shi Y, Xiao T, Fu J, Feng X, Mu D, et al. Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition) Ann Transl Med. 2020;8(3):47. doi: 10.21037/atm.2020.02.20.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する